skip to main content
Idioma:
Mostrar Somente
Refinado por: tipo de recurso: Outros remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Monetary policy propects
Monetary policy propects
Material Type:
Outros 		Adicionar ao Meu Espaço

Monetary policy propects

Antônio Delfim Netto 1928-

S.l. s.n 19--

Localização: FEA - Fac. Econ. Adm. Contab. e Atuária  ACERVO DELFIM NETTO  (B23.22.41 )(Acessar)

2
Revista Brasileira de Biociências
Revista Brasileira de Biociências
Material Type:
Outros 		Adicionar ao Meu Espaço

Revista Brasileira de Biociências

Ana Maria Giulietti Angela Borges Martins; Dorothy Sue Dunn de Araújo; Élgion Lúcio da Silva Loreto; Francisco de Assis Esteves; Francisco Moura Salzano; Helga Winge; Hilda Maria Longhi-Wagner; Ilce Maria de Syllos Cólus; Jorge Alberto Quillfeldt; Jorge Luiz Waechter; Luiz Roberto Malabarba; Marcelo dos Santos Guerra Filho; Maria Helena Mainieri Galileo; Mário Berbardo Filho; Marta Elena Fabián; Monica Montu; Reinaldo Monteiro; Tarciso S Filgueiras; Waldir Mantovani

Rio Grande do Sul 2003

Item não circula. Consulte sua biblioteca.(Acessar)

3
Microstratigraphic evidence of in situ fire in the acheulean strata of wonderwek cave, northern cape province, South Africa
Microstratigraphic evidence of in situ fire in the acheulean strata of wonderwek cave, northern cape province, South Africa
Material Type:
Outros 		Adicionar ao Meu Espaço

Microstratigraphic evidence of in situ fire in the acheulean strata of wonderwek cave, northern cape province, South Africa

Antônio Delfim Netto 1928-

S.l. s.n. 20--

Localização: FEA - Fac. Econ. Adm. Contab. e Atuária  ACERVO DELFIM NETTO  (C6.10.34 )(Acessar)

4
Banda fiscal
Banda fiscal
Material Type:
Outros 		Adicionar ao Meu Espaço

Banda fiscal

Antônio Delfim Netto 1928-

S.l. s.n. 200-

Localização: FEA - Fac. Econ. Adm. Contab. e Atuária  ACERVO DELFIM NETTO  (B27.4.7 )(Acessar)

5
Exposure Response (ER) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer
Exposure Response (ER) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer
Material Type:
Outros 		Adicionar ao Meu Espaço

Exposure Response (ER) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer

Matulonis, UA ; Moore, K ; Lorusso, D ; Oaknin, A ; Pignata, S ; Denys, H ; Colombo, N ; Van Gorp, Toon ; Konner, J ; Romeo, M ; Harter, P ; Murphy, C ; O'Malley, D ; Yu, T ; Esteves, B ; Method, M ; Birrer, M ; Coleman, RL

Annals Of Oncology, 2022, Vol.33 (S7), p.S817-S817

Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
6
Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study
Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study
Material Type:
Outros 		Adicionar ao Meu Espaço

Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study

Matulonis, Ursula ; Lorusso, Domenica ; Oaknin, Ana ; Pignata, Sandro ; Denys, H ; Colombo, Nicoletta ; Van Gorp, T ; Konner, Jason ; Romeo Marin, Margarita ; Harter, Philipp ; Murphy, Conleth ; Wang, Jiuzhou ; Noble, Elizabeth ; Esteves, Brooke ; Method, Michael ; Coleman, Robert

Gynecologic Oncology, 2022, Vol.166/S1, p.S50-S50

Elsevier

Texto completo disponível

Citações Citado por
7
Mirvetuximab Soravtansine (MIRV) in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha (FRα) Expression: Characterization of Anti-Tumor Activity in the SORAYA Study
Mirvetuximab Soravtansine (MIRV) in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha (FRα) Expression: Characterization of Anti-Tumor Activity in the SORAYA Study
Material Type:
Outros 		Adicionar ao Meu Espaço

Mirvetuximab Soravtansine (MIRV) in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha (FRα) Expression: Characterization of Anti-Tumor Activity in the SORAYA Study

Matulonis, Ursula A ; Oaknin, Ana ; Pignata, Sandro ; Denys, Hannelore ; Colombo, Nicoletta ; Van Gorp, T ; Konner, Jason ; Harter, Philipp ; Wang, Jiuzhou ; Esteves, Brooke ; Method, Michael ; Coleman, Robert L ; Lorusso, Domenica

Journal Of Clinical Oncology, 2022, Vol.40 (16_Suppl), p.5512-5512

American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Named Entity Recognition in Twitter using Images and Text: Published on arXiv
Named Entity Recognition in Twitter using Images and Text: Published on arXiv
Material Type:
Outros 		Adicionar ao Meu Espaço

Named Entity Recognition in Twitter using Images and Text: Published on arXiv

Esteves, Diego ; Peres, Rafael ; Lehmann, Jens ; Napolitano, Giulio

2017

Texto completo disponível

Citações Citado por
9
Population Pharmacokinetic (PK) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer
Population Pharmacokinetic (PK) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer
Material Type:
Outros 		Adicionar ao Meu Espaço

Population Pharmacokinetic (PK) Analysis of Mirvetuximab Soravtansine (MIRV) in Patients With Folate Receptor α (FRα)-Positive Cancer

Moore, K ; Lorusso, D ; Oaknin, A ; Pignata, S ; Denys, H ; Colombo, N ; Van Gorp, Toon ; Konner, J ; Romeo, M ; Harter, P ; Murphy, C ; O'Malley, D ; Tu, Y ; Zhu, F ; Esteves, B ; Method, M ; Birrer, M ; Coleman, RL ; Matulonis, UA

Annals Of Oncology, 2022, Vol.33 (S7), p.S822-S823

Oxford University Press (OUP)

Texto completo disponível

Citações Citado por
10
Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer
Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer
Material Type:
Outros 		Adicionar ao Meu Espaço

Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer

Moore, KN ; Lorusso, D ; Oaknin, A ; Pignata, S ; Denys, H ; Colombo, N ; Van Gorp, T ; Konner, J ; Romeo Marin, M ; Harter, P ; Murphy, C ; Tu, Y ; Zhu, F ; Esteves, B ; Method, M ; Birrer, MJ ; Coleman, RL ; Matulonis, UA ; O'Malley, D

ANNALS OF ONCOLOGY, 2022, Vol.33 (7), p.S822-S823

ELSEVIER

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (8)
  2. Disponível na Biblioteca (3)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Delfim Netto, A
  2. Fabián, M
  3. Filgueiras, T
  4. Montu, M
  5. Winge, H

Neste Assunto:

  1. Dívida Pública
  2. Economia
  3. Meio Ambiente
  4. Paleontologia
  5. Marxismo

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.